To meet the growing global demand for respiratory active pharmaceutical ingredients (APIs), Inke is to invest €9 million into its production plant to reinforce focus on inhalation micronised APIs
The facility will support clinical development by securing supply that will address the critical demand in the gene therapy and vaccine markets
Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey
New product line to address the challenge of restrictions on use of plastic straws
The HD-550 endoscopy system has been available outside of the USA since 2019
Rodolfo brings with him a wealth of rich experience from commercial, marketing, and general management roles across several multinational companies
The association has lined up a string of prominent speakers from the government and private sector. Seasoned veterans and industry bigwigs will grace the two-day event in Mumbai
A comprehensive assessment of the organisational systems for governance, management, operations and consistency in delivered results, this certification is an endorsement of the company's export capabilities and manufacturing prowess
The site consists of five fermentation "mini-factories" capable of concurrently producing our more than 13 currently scaled and future bio-fermented products
The recombinant nanoparticle-based rabies G protein vaccine is prepared using virus-like particle technology.
Subscribe To Our Newsletter & Stay Updated
